Journey Medical Corporation ( DERM) - Key Metrics
DERM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.67 | -$0.01 | -$0.06 | -$0.06 |
| 2026Q1 | $0.58 | -$0.08 | $0.11 | $0.11 |
| 2025Q4 | $0.66 | -$0.05 | -$0.26 | -$0.26 |
| 2025Q3 | $0.71 | -$0.09 | -$0.10 | -$0.10 |
| 2025Q2 | $0.64 | -$0.16 | -$0.04 | -$0.04 |
DERM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -177 |
| 2026Q1 | 0% | -14.66 |
| 2025Q4 | 0% | -41.99 |
| 2025Q3 | 0% | -19.78 |
| 2025Q2 | 0% | -11.22 |
DERM
Price: $5.12
52 week price:
Earnings Per Share: -0.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 25200
Ebitda: -176.2 millionMarket Capitalization: 165.7 million